The Role of MicroRNAs in Colorectal Cancer.
10.4166/kjg.2017.69.4.206
- Author:
Sang Wook KIM
1
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea. clickm@jbnu.ac.kr
- Publication Type:Review
- Keywords:
MicroRNAs;
Colorectal cancer
- MeSH:
Animals;
Apoptosis;
Biomarkers;
Carcinogenesis;
Cell Cycle;
Colorectal Neoplasms*;
Diagnosis;
Genes, Tumor Suppressor;
Inflammation;
MicroRNAs*;
Negotiating;
Oncogenes;
RNA
- From:The Korean Journal of Gastroenterology
2017;69(4):206-211
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Colorectal cancer (CRC) is one of the leading causes of cancer related deaths in the world. Many oncogenes and tumor suppressor genes are involved in the development of CRC. MicroRNAs (miRNAs) are a class of small, non-coding, endogenous RNAs in animals and plants. Recent studies have shown that miRNAs are associated with the mediation process of tumorigenesis, including inflammation, cell cycle, stress response, differentiation, apoptosis, migration, and invasion in cancer. These miRNAs have been linked to the development of CRC and recently studied as new potential biomarkers in the diagnosis and treatment for CRC. Specific miRNAs expression patterns help distinguish CRC from other colon-related diseases, and miRNAs can target the oncogenes and regulatory molecular pathways. Recent studies have demonstrated the restoration of tumor suppressive miRNAs and inhibition of oncogenic miRNAs for CRC treatment. Herein, we describe the diagnostic and therapeutic roles of miRNAs in CRC.
